bimatoprost and Myopia

bimatoprost has been researched along with Myopia* in 1 studies

Other Studies

1 other study(ies) available for bimatoprost and Myopia

Article	Year
Bimatoprost (0.03%)-induced accommodative spasm and pseudomyopia. BMJ case reports, 2015, Nov-23, Volume: 2015 Bimatoprost is a prostaglandin analogue used topically in the treatment of glaucoma. Commonly known side effects include eyelash growth, iris pigmentation and conjunctival hyperemia. While pseudomyopia is reported to be caused by parasympathomimetics, such an effect precipitated by bimatoprost has not yet been reported. We report a case demonstrating pseudomyopia and accommodative spasm caused after starting bimatoprost 0.03% in a young patient with glaucoma. Topics: Antihypertensive Agents; Bimatoprost; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Myopia; Oculomotor Muscles; Spasm; Treatment Outcome	2015

Article

Year

Bimatoprost (0.03%)-induced accommodative spasm and pseudomyopia.

BMJ case reports, 2015, Nov-23, Volume: 2015

Bimatoprost is a prostaglandin analogue used topically in the treatment of glaucoma. Commonly known side effects include eyelash growth, iris pigmentation and conjunctival hyperemia. While pseudomyopia is reported to be caused by parasympathomimetics, such an effect precipitated by bimatoprost has not yet been reported. We report a case demonstrating pseudomyopia and accommodative spasm caused after starting bimatoprost 0.03% in a young patient with glaucoma.

Topics: Antihypertensive Agents; Bimatoprost; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Myopia; Oculomotor Muscles; Spasm; Treatment Outcome

2015